SLC1A1 Antilichaam - N-terminalgebied: FITC (ARP43865 P050-FITC)

Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1

DCBXA, EAAC1, EAAT3, SCZD18

6505

P43005

NP_004161

Human, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human SLC1A1

SLC1A1 transports L-glutamate and also L- and D-aspartate. It is essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. SLC1A1 acts as a symport by cotransporting sodium. It negatively regulated by ARL6IP5.

LDLRAD1; RNF5; APP; ARL6IP5; PRKCA; EWSR1

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

SLC1A1 is strongly supported by BioGPS gene expression data to be expressed in 721_B

0.5 mg/ml

Human: 100%; Rabbit: 86%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

57kDa

Ruggiero, A.M., (2008) J. Biol. Chem. 283 (10), 6175-6183

Wet Ice

524

SLC1A1

SLC1A1

Rabbit

Excitatory amino acid transporter 3

NM_004170

VLVREHSNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSN